Lack of access to chemotherapy for colon cancer: Multiplicative disadvantage of being extremely poor, inadequately insured and African American

BMC Health Services Research

Volumn 14, Issue , 2014, Pages

  Gorey, Kevin M ^a   Haji Jama, Sundus ^a   Bartfay, Emma ^b   Luginaah, Isaac N ^c   Wright, Frances C ^d   Kanjeekal, Sindu M ^e  

^a UNIVERSITY OF WINDSOR   (Canada)

^b UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Centre Regional De Cancerologie De Windsor   (Canada)

Author keywords

African American; California; Chemotherapy; Colon cancer; Ethnicity; Health care reform; Health insurance; Poverty; Underinsured; Uninsured; United States

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; CANCER STAGING; COLONIC NEOPLASMS; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MALE; MEDICALLY UNINSURED; MIDDLE AGED; PATHOLOGY; POVERTY; REGISTER; RISK FACTOR; SOCIAL CLASS; UNITED STATES; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CALIFORNIA; COLONIC NEOPLASMS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; NEOPLASM STAGING; POVERTY AREAS; REGISTRIES; RISK FACTORS; SOCIAL CLASS;

EID: 84897985900     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-133     Document Type: Article

References (46)

1. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM, J Clin Oncol 2004 22 1797 1806 10.1200/JCO.2004.09.059 15067028
2. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, Shepherd LE, Seitz JF, Francini G, N Engl J Med 2001 345 1091 1097 10.1056/NEJMoa010957 11596588
3. Adjuvant therapy for completely resected stage II colon cancer. Figueredo A, Coombes ME, Mukherjee S, Cochrane Database Syst Rev 2008 4
4. Supportive care for patients with gastrointestinal cancer. Ahmed N, Ahmedzai S, Vora V, Hillam S, Paz S, Cochrane Database Syst Rev 2009 4
5. Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review. Etzioni DA, El-Khoueiry AB, Beart RW Jr, Cancer 2008 113 3279 3289 10.1002/cncr.23958 18951522
6. DeNavas-Walt C, Proctor BD, Smith JC, US Census Bureau, Current Population Reports (P60-245), Income, Poverty, and Health Insurance Coverage in the United States: 2011 Washington, DC: US Government Printing Office 2012
7. Conley D, Being Black, Living in the red: Race, Wealth, and Social Policy in America Los Angeles, CA: University of California Press 1999
8. Disparities in colorectal cancer in African-Americans vs whites: before and after diagnosis. Dimou A, Syrigos KN, Saif MW, World J Gastroenterol 2009 15 3734 3743 10.3748/wjg.15.3734 19673013
9. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW, ACCENT Collaborative Group, J Natl Cancer Inst 2011 103 1498 1506 10.1093/jnci/djr310 21997132
10. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Du XL, Meyer TE, Franzini L, Cancer 2007 109 2161 2170 10.1002/cncr.22664 17455219
11. Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults. Mack CD, Carpenter W, Meyer A, Sanoff H, Stürmer T, Cancer 2012 118 2925 2934 10.1002/cncr.26622 22072441
12. A black-white comparison of the quality of stage-specific colon cancer treatment. Berry J, Caplan L, Davis S, Minor P, Counts-Spriggs M, Glover R, Ogunlade V, Bumpers K, Kauh J, Brawley OW, Flowers C, Cancer 2010 116 713 722 10.1002/cncr.24757 19950126
13. Impact of race on colorectal cancer. Sabounchi S, Keihanian S, Anand BS, Clin Colorectal Cancer 2012 11 66 70 10.1016/j.clcc.2011.03.026 21729674
14. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL, J Natl Cancer Inst 2009 101 984 992 10.1093/jnci/djp175 19584328
15. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG, Can J Surg 2009 52 92 97 19399202
16. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Gorey KM, Holowaty EJ, Fehringer G, Laukkanen E, Moskowitz A, Webster DJ, Richter NL, Am J Public Health 1997 87 1156 1163 10.2105/AJPH.87.7.1156 9240106
17. Better colon cancer care for extremely poor Canadian women compared with American women. Gorey KM, Luginaah IN, Bartfay E, Zou GY, Haji-Jama S, Holowaty EJ, Hamm C, Kanjeekal SM, Wright FC, Balagurusamy MK, Richter NL, Health Soc Work 2013 38 240 248 10.1093/hsw/hlt022 24432491
18. Effects of being uninsured or underinsured and living in high poverty neighborhoods on colon cancer care and survival in California: Historical cohort analysis, 1996-2011. Gorey KM, Luginaah IN, Holowaty EJ, Zou G, Hamm C, Bartfay E, Kanjeekal SM, Balagurusamy MK, Haji-Jama S, Wright FC, BMC Public Health 2012 12 897 10.1186/1471-2458-12-897 23092403
19. Wilson WJ, The truly disadvantaged: The inner city, the underclass, and public policy Chicago, IL: University of Chicago Press 2 2012
20. Stunning progress, hidden problems: the dramatic decline of concentrated poverty in the 1990s. Jargowsky PA, Redefining Urban and Suburban America: Evidence from Census 2000, Vol 2 Washington, DC: Brookings Institution Press, Berube A, Katz B, Lang RE, 2005 137 171
21. Jargowsky PA, Poverty and Place: Ghettos, Barrios, and the American City New York: Russell Sage Foundation 1997
22. Iceland J, Poverty in America: A Handbook Los Angeles, CA: University of California Press 2003
23. Dalaker J, US Census Bureau, Current Population Reports (P60-214), Poverty in the United States: 2000 Washington, DC: US Government Printing Office 2001
24. Mediation of the effects of living in extremely poor neighborhoods by health insurance: breast cancer care and survival in California, 1996 to 2011. Gorey KM, Luginaah IN, Holowaty EJ, Zou GY, Hamm C, Balagurusamy MK, Int J Equity Health 2013 12 6 10.1186/1475-9276-12-6 23311824
25. Health insurance mediation of the Mexican American non-Hispanic white disparity on early breast cancer diagnosis. Haji-Jama S, Gorey KM, Luginaah IN, Balagurusamy MK, Hamm C, SpringerPlus 2013 2 285 10.1186/2193-1801-2-285 23853754
26. Care and survival of Mexican American women with node negative breast cancer: Historical cohort evidence of health insurance and barrio advantages. Richter NL, Gorey KM, Haji-Jama S, Luginaah IN, J Immigr Minor Health in press
27. Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006. Gorey KM, Luginaah IN, Bartfay E, Fung KY, Holowaty EJ, Wright FC, Hamm C, Kanjeekal SM, Am J Public Health 2011 101 112 119 10.2105/AJPH.2009.173112 20299655
28. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, American Joint Committee on Cancer: AJCC Cancer Staging Manual New York: Springer- Verlag 6 2002
29. Brant MK, Ziegler KL, California Cancer Reporting System Standards: Abstracting and Coding Procedures for Hospitals (Vol 1 Sacramento, CA: California Cancer Registry 13 2013
30. Hosmer DW, Lemeshow S, Applied Logistic Regression New York: John Wiley & Sons 2 2000
31. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE, Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models New York: Springer 2 2012
32. On median tests for linear hypotheses. Brown GW, Mood AM, Proceedings of the Second Berkeley Symposium on Mathematical Statistics and Probability, 159-66 Los Angeles, CA: University of California Press, Neyman J, 1951
33. Shapiro T, Meschede T, Osoro S, The roots of the widening racial wealth gap: Explaining the black-white economic divide Waltham, MA: Institute on Assets and Social Policy, Brandeis University 2013
34. Shapiro TM, The hidden cost of being African American: How wealth perpetuates inequality New York: Oxford University Press 2004
35. US Cancer Statistics Working Group, United States Cancer Statistics: 1999-2007 Incidence and Mortality Atlanta, GA: Centers for Disease Control and Prevention, and National Cancer Institute 2010
36. US Census Bureau, Current Population Survey. Annual Social and Economic Supplement: 2011 Washington, DC: US Government Printing Office 2012
37. Applications of stratified analysis methods. Greenland S, Modern Epidemiology, 283-302 Philadelphia, PA: Lippincott, Williams and Wilkins, Rothman KJ, Greenland S, Lash TL, 2008
38. The burden of disease and injury in the United States 1996. Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, Ebrahim S, Ezzati M, Salomon JA, Kreiser JG, Hogan M, Murray CJL, Popul Health Metr 2006 4 11 10.1186/1478-7954-4-11 17049081
39. Risk factors for financial hardship patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. Shankaran V, Jolly S, Blough D, Ramsey SD, J Clin Oncol 2012 30 1608 1614 10.1200/JCO.2011.37.9511 22412136
40. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Cress RD, Zaslavsky AM, West DW, Wolf RE, Felter MC, Ayanian AZ, Med Care 2003 41 1006 1012 10.1097/01.MLR.0000083740. 12949.88 12972840
41. Completeness of American cancer registry treatment data: implications for quality of care research. Mallin K, Palis BE, Watroba N, Stewart AK, Walczak D, Singer J, Barron J, Blumenthal W, Haydu G, Edge SB, J Am Coll Surg 2013 216 428 437 10.1016/j.jamcollsurg.2012.12.016 23357724
42. Validity of cancer registry Medicaid status against enrollment files: implications for population-based studies of cancer outcomes. Chan JK, Gomez SL, O'Malley CD, Perkins CI, Clarke CA, Med Care 2006 44 952 955 10.1097/01.mlr.0000220830.46929.43 17001267
43. Using cancer registry data for survival studies: the example of the Ontario cancer registry. Hall S, Schulze K, Groome P, Mackillop W, Holowaty E, J Clin Epidemiol 2006 59 67 76 10.1016/j.jclinepi.2005.05.001 16360563
44. Verrill C, Assessing the Reliability and Validity of Primary Payer Information in Central Cancer Registry Data Quebec City: Annual meeting of the North American Association of Central Cancer Registries 2010
45. Bias due to misclassification in the estimation of relative risk. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH, Am J Epidemiol 1977 105 488 495 871121
46. How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null? Jurek AM, Greenland S, Maldonado G, Int J Epidemiol 2008 37 382 385 10.1093/ije/dym291 18184671